Table 16 Normalized decision matrix.
From: Role of topological indices in predictive modeling and ranking of drugs treating eye disorders
Alternatives | \({\varvec{mMsde}}\left( {\varvec{G}} \right)\) | \({\varvec{HM}}\left( {\varvec{G}} \right)\) | \({\varvec{ReZG}}_{2} \left( {\varvec{G}} \right)\) | \({\varvec{M}}_{1} \left( {\varvec{G}} \right)\) | \({\varvec{M}}_{2} \left( {\varvec{G}} \right)\) |
|---|---|---|---|---|---|
Acetazolamide | 0.686347 | 0.686347 | 0.635047 | 0.666667 | 0.585714 |
Acetylcysteine | 1 | 1 | 1 | 1 | 1 |
Aciclovir | 0.636675 | 0.636675 | 0.459885 | 0.5 | 0.44086 |
Tropicamide | 0.513407 | 0.513407 | 0.362696 | 0.4 | 0.359649 |
Xylometazoline | 0.527553 | 0.527553 | 0.399362 | 0.416667 | 0.359649 |
Apraclonidine | 0.651326 | 0.651326 | 0.491317 | 0.526316 | 0.471264 |
Brinzolamide | 0.457645 | 0.457645 | 0.369886 | 0.377358 | 0.328 |
Bromfenac | 0.540249 | 0.540249 | 0.380477 | 0.416667 | 0.376147 |
Carteolol | 0.450519 | 0.450519 | 0.36496 | 0.377358 | 0.347458 |
Cyclopentolate | 0.480798 | 0.480798 | 0.361948 | 0.384615 | 0.344538 |
Lodoxamide | 0.51119 | 0.51119 | 0.428851 | 0.444444 | 0.405941 |
Ganciclovir | 0.553101 | 0.553101 | 0.411158 | 0.444444 | 0.390476 |
